Basics Atyr Pharma, Inc. IPO Date: May 12, 2015 Sector: Healthcare Industry: Biotech Market Cap: $99.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.67% Avg Daily Range (30 D): $0.08 | 5.27% Avg Daily Range (90 D): $0.16 | 4.22% Institutional Daily Volume Avg Daily Volume: .38M Avg Daily Volume (30 D): 16.54M Avg Daily Volume (90 D): 8.4M Trade Size Avg Trade Size (Sh.): 252 Avg Trade Size (Sh.) (30 D): 471 Avg Trade Size (Sh.) (90 D): 302 Institutional Trades Total Inst.Trades: 121 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $1.52M Avg Inst. Trade (90 D): $1.63M Avg Inst. Trade Volume: .48M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $1.62M Avg Closing Trade (90 D): $1.74M Avg Closing Volume: 452.46K     News Oct 17, 2025 @ 4:00 PM ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman Llc Oct 13, 2025 @ 8:00 PM Contact The Gross Law Firm by December 8, 2025 Dea... Source: The Gross Law Firm Oct 12, 2025 @ 12:44 PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages a... Source: Rosen Law Firm Oct 10, 2025 @ 11:24 PM ATYR Investor Notice: Robbins LLP Reminds Investor... Source: Robbins Llp Oct 10, 2025 @ 5:51 PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ... Source: James (Josh) Wilson Financials   TTM Q1 2025 FY 2024 Basic EPS $-.22 $-.17 $-.86 Diluted EPS $-.22 $-.17 $-.86 Revenue $ M $ M $ .24M Gross Profit $ $ $ Net Income / Loss $ -19.53M $ -14.88M $ -64.02M Operating Income / Loss $ -20.31M $ -15.77M $ -67.91M Cost of Revenue $ $ $ Net Cash Flow $ 7.3M $ -1.21M $ -12.02M PE Ratio